CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
By K. F. Schulz, Douglas G. Altman, David Moher. PLoS Medicine, 2010
1,423 citations recorded by the source corpus.
Kenneth Schulz and colleagues describe the 2010 version of the CONSORT Statement, which updates the previous reporting guideline based on new methodological evidence and accumulated experience.
Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/433614cfe2dec7be6e55cd7ecc785f94ca74bbea
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Gary S. Collins
- Johannes B Reitsma
- Karel G. M. Moons
- Douglas G. Altman
- Ewout W. Steyerberg
- Andrew J. Vickers
- Y. Vergouwe
- Patrick Royston
In Economics and Econometrics
- Gary S. Collins
- Karel G. M. Moons
- Johannes B Reitsma
- Douglas G. Altman
- Ewout W. Steyerberg
- Andrew J. Vickers
- C. Kilkenny
- Innes C. Cuthill
In Statistics and Probability
- Gary S. Collins
- Karel G. M. Moons
- Johannes B Reitsma
- Douglas G. Altman
- Ewout W. Steyerberg
- Andrew J. Vickers
- Innes C. Cuthill
- Petra Macaskill
Citations in the corpus
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration (2015, positive): “Reporting guidelines for randomized trials (CONSORT [96]), observational studies (STROBE [97]), tumor marker studies (REMARK [98]), molecular epidemiology (STROBE-ME [99]), diagnostic accuracy (STARD [100]), and genetic risk prediction studies (GRIPS [101]) contain items that are relevant to all typ”
- Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy (2017, neutral): “The only study to meet all Consolidated Standards of Reporting Trials criteria and measure 1-year outcome was the Weaver and colleagues trial (82, 91).”
- Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research (2010, positive): “The guidelines, referred to as ARRIVE (Animals in Research: Reporting In vivo Experiments), have been developed using the CONSORT Statement as their foundation.[24,25]”
- Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012, neutral): “Future trials should report the blinding status of these groups, as specified in the CONSORT (Consolidated Standards of Reporting Trials) Statement (35, 36).”
- Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines (2011, neutral): “…analysed 15 (a) Report the number of animals in each group included in each analysis; report absolute numbers (e.g., 10/20, not 50% (Schulz et al, 2010)); (b) if any animals or data were not included in the analysis, explain why Outcomes and estimation 16 Report the results for…”